Back
Vistra Vs. Neurogene Industry Stock Comparison
Buy
80
VST
Vistra
Last Price:
142.16
Seasonality Move:
6.49%
Sell
13
NGNE
Neurogene
Last Price:
39.61
Seasonality Move:
50.43%
Buy
80
Vistra (VST)
is a Buy
Is Vistra a Buy, Sell or Hold?
- The current Vistra [VST] share price is $142.16. The Score for VST is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
- VST is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
13
Neurogene (NGNE)
is a Sell
Is Neurogene a Buy, Sell or Hold?
- The current Neurogene [NGNE] share price is $40.00. The Score for NGNE is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
- NGNE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
VST Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.79 | Buy |
Relative Strength Index (14 RSI): | 64.6 | Buy |
Chaikin Money Flow: | 660421 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
NGNE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.99 | Buy |
Relative Strength Index (14 RSI): | 39.4 | Sell |
Chaikin Money Flow: | -718137 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
VST Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 131.1 | Buy |
20-day SMA: | 128.93 | Buy |
50-day SMA: | 114.55 | Buy |
200-day SMA: | 84.38 | Buy |
8-day EMA: | 135.16 | Buy |
20-day EMA: | 129.21 | Buy |
50-day EMA: | 117.49 | Buy |
200-day EMA: | 87.38 | Buy |
NGNE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 61.21 | Sell |
20-day SMA: | 53.69 | Sell |
50-day SMA: | 46.52 | Sell |
200-day SMA: | 38.9 | Buy |
8-day EMA: | 58.17 | Sell |
20-day EMA: | 54.62 | Sell |
50-day EMA: | 48.72 | Sell |
200-day EMA: | 38.46 | Buy |
Vistra Earnings Growth & VST Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.76 per share, and an increase next year of $2.06 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.
Vistra Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Neurogene Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |